Truepill preps launch of virtual COVID-19 service for oral antiviralsTelehealth, diagnostics and pharmacy business Truepill will launch a new virtual care platform in the coming weeks that Share XTruepill preps launch of virtual COVID-19 service for oral antiviralshttps://pharmaphorum.com/news/truepill-preps-launch-of-virtual-covid-19-service-for-oral-antivirals/
Merck’s oral COVID drug squeaks past FDA advisory committeeAn FDA advisory committee voted by 13 to 10 to recommend emergency-use authorisation for Merck & Co and Share XMerck’s oral COVID drug squeaks past FDA advisory committeehttps://pharmaphorum.com/news/mercks-oral-covid-drug-squeaks-past-fda-advisory-committee/
Fall in efficacy of Merck’s molnupiravir puts Pfizer in driver’s seatMerck & Co has reported new data with its oral antiviral molnupiravir that suggests it is not as Share XFall in efficacy of Merck’s molnupiravir puts Pfizer in driver’s seathttps://pharmaphorum.com/news/fall-in-efficacy-of-mercks-molnupiravir-puts-pfizer-in-drivers-seat/
Pfizer gets bumper $5.3bn order from US for oral COVID drugAlready making big profits from its COVID-19 vaccine, Pfizer looks set to bolt on another big revenue stream Share XPfizer gets bumper $5.3bn order from US for oral COVID drughttps://pharmaphorum.com/news/pfizer-gets-bumper-5-3bn-order-from-us-for-oral-covid-drug/
Pfizer files oral COVID pill in US, signs access deal for 95 countriesArmed with impressive new data for its oral antiviral Paxlovid, Pfizer has filed for emergency use authorisation as Share XPfizer files oral COVID pill in US, signs access deal for 95 countrieshttps://pharmaphorum.com/news/pfizer-files-oral-covid-pill-in-us-signs-access-deal-for-95-countries/
Pfizer’s pill cuts COVID deaths and hospitalisations by 90%An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or Share XPfizer’s pill cuts COVID deaths and hospitalisations by 90%https://pharmaphorum.com/news/pfizers-pill-cuts-covid-deaths-and-hospitalisations-by-90/
